It is to measure risk more accurately, think in cumulative exposure rather than 10-year probability, use apoB where standard markers are most likely to understate burden, intervene earlier when trajectory, family history, metabolic phenotype, or imaging warrant it, and keep treatment intensity proportional to both the evidence and the person in the consulting room
Love it, so convenient and simple
Due to the compounds plasma half-life of approximately 3.86.9 hours [4] , twice-daily (BID) dosing may provide more sustained NNMT inhibition
References Heffernan MA, et al
The synergy of BPC, KPV and PEA, offers a comprehensive approach often used to support inflammation, gut health, and conditions such as Inflammatory Bowel Disease ( IBD )